Kolkata: The allotment of Goldline Pharmaceutical will take place today, May 15, 2026. In the dull IPO segment of the stock market, this pharma company has attracted the highest bids of this year by getting applications that is 840.74 times the Rs 11.61 crore that the company set out to mobilise at the outset. The NII category recorded 1,662.04 times bids of the portion earmarked for them, while retail investors put subscriptions 881.15 times their category. The QIB investors bid 180.22 times of their part. The company put up for sale 19.68 lakh fresh equity shares. The SME issue shines in the tepid market when only 20 mainboard IPOs have been listed in 2026 so far. Naturally a lot of bidders will be eager to know whether he/she has been allotted the shares applied for. Let’s have a look at how one can find out the allotment status later in the day through a simple steps one can take online.
Checking allotment via BSE
Goldline Pharmaceutical will be listed in the BSE SME segment. Therefore, one can check the allotment status in the BSE portal. One can take the following steps.
ONE: Go to the BSE Investor Services website
TWO: Under Issue Type, select Equity
THREE: Select “Goldline Pharmaceutical Ltd” under Issue Name
FOUR: Type in your Application Number and PAN Number
FIVE: Click ‘Search’ and the status will show on the screen
Checking allotment via Bigshare Services
Bigshare Services is the registrar to the Goldline Pharmaceutical IPO. Therefore, one can also check the fate of the application in its portal.
ONE: Enter the Bigshare Services website
TWO: Go to the Bigshare Services IPO allotment page
THREE: Proceed to Select Company dropdown menu
FOUR: Select “Goldline Pharmaceutical Ltd”
FIVE: Choose Application Number or PAN or Demat Account Number (Beneficiary ID) and fill the required details
SIX: Fill in the captcha and click Search
Goldline Pharmaceutical IPO GMP
According to investorgain, Goldline Pharmaceutical IPO GMP stood at Rs 15 in late night of May 14. Considering the price band at Rs 43.00, the estimated listing price of Goldline Pharmaceutical shares will be Rs 58 and the listing gain 34.88%. The GMP declined from the level of Rs 25. However, it must be remembered that GMP is an unofficial indicator that could be volatile and cannot guarantee any listing gain. Let’s see how the GMP of this SME IPO has steadily moved up over the past few days.
(Disclaimer: This article is only meant to provide information. News9 does not recommend buying or selling shares or subscriptions of any IPO, Mutual Funds, precious metals, commodity, REITs, InvITs and any form of alternative investment instruments and crypto assets.)